Initial Prior Authorization with Quantity Limit Opzelura
Customize your policy alerts
Sign up for cvs_caremark Policy 5018-C alerts
Get alerted when Policy 5018-C changes without checking for updates manually.
Monitor payer policy activity
This policy governs initial and continuation prior authorization for Opzelura cream, including coverage criteria for atopic dermatitis and nonsegmental vitiligo and applicable quantity limits. It applies to adult and pediatric patients meeting the condition-specific age, clinical response, body surface area, and treatment-use requirements.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.